2025-03-28 18:55:33
Latest Post
Maithan A1loys Limited purchases 1.99 lakh shares of NSE
Lancor Holdings Ltd updates on new projects
Scheme of amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals has been sanctioned by NCLT
AstraZeneca Pharma India Ltd to discontinue the manufacturing and marketing of Imdur from April 1, 2025
Aerolloy Technologies secures major order from Safran Aircraft Engines for LEAP Engine Cast Components
Stock Report
Epigral Ltd Q4 FY24 consolidated PAT jumps QoQ to Rs. 77.27 crores
Posted On : 2024-04-22 22:04:44( TIMEZONE : IST )
Meghmani Finechem Ltd has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 526.1557 crores during the period ended March 31, 2024 as compared to Rs. 473.9841 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 77.2786 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 49.0841 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 18.60 for the period ended March 31, 2024 as compared to Rs. 11.81 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 526.1557 crs | ₹473.9841 crs |  11.01% |
| Net Profit | ₹77.2786 crs | ₹49.0841 crs | 57.44% |
| EPS | ₹18.60 | ₹11.81 | 57.49% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 526.1557 crores during the period ended March 31, 2024 as compared to Rs.566.7153 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.77.2786 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.76.7331 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.18.60 for the period ended March 31, 2024 as compared to Rs.18.47 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 526.1557 crs | ₹566.7153 crs |  -7.16% |
| Net Profit | ₹77.2786 crs | ₹76.7331 crs | 0.71% |
| EPS | ₹18.60 | ₹18.47 | 0.70% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.1935.7066 crores during the Financial Year ended March 31, 2024 as compared to Rs.2196.3836 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.195.8159 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.353.2906 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.47.13 for the Financial Year ended March 31, 2024 as compared to Rs.85.03 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹1935.7066 crs | ₹2196.3836 crs | -11.87% |
| Net Profit | ₹195.8159 crs | ₹353.2906 crs | -44.57% |
| EPS | ₹47.13 | ₹85.03 | -44.57% |
Shares of Meghmani Finechem Ltd was last trading in BSE at Rs. 1403.35 as compared to the previous close of Rs. 1319.10. The total number of shares traded during the day was 36416 in over 10722 trades.
The stock hit an intraday high of Rs. 1430.00 and intraday low of 1291.00. The net turnover during the day was Rs. 50095590.00.
